RESULTS	HR for the recurrence of cerebral infarction with sarpogrelate versus that with aspirin was 0.87 ( 95 % CI : 0.48 to 1.60 ) in diabetic patients and 1.51 ( 95 % CI : 0.98 to 2.31 ) in nondiabetic patients .\